E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Zhang SK, Guo LW, Chen Q, et al. The association between human papillomavirus 16 and esophageal cancer in Chinese population: a meta-analysis. BMC Cancer. 2015;15:1096.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu X, Liu X, et al. Long noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis. Bioengineered. 2021;12:6687–6702.
   PubMed Web of Science ®Google Scholar
• Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg. 2013;61:330–335.
   PubMedGoogle Scholar
• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381:400–412.
   PubMed Web of Science ®Google Scholar
• Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14:33–41.
   PubMed Web of Science ®Google Scholar
• Xanthoulis A, Tiniakos DG. E2F transcription factors and digestive system malignancies: how much do we know? World J Gastroenterol. 2013;19:3189–3198.
   PubMed Web of Science ®Google Scholar
• Luo H, Tao C, Long X, et al. Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma. Bioengineered. 2021;12:7765–7779.
   PubMed Web of Science ®Google Scholar
• Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer. 2009;9:785–797.
   PubMed Web of Science ®Google Scholar
• Xu Z, Wu Z, Zhang J, et al. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis. Biomed Res Int. 2020;2020:5603958.
   PubMed Web of Science ®Google Scholar
• Li P, Lin XJ, Yang Y, et al. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma. Cell Death Dis. 2019;10:916.
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Hanazawa T, Nohata N, et al. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. J Hum Genet. 2012;57:556–563.
   PubMed Web of Science ®Google Scholar
• Nohata N, Hanazawa T, Kikkawa N, et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet. 2011;56:595–601.
   PubMed Web of Science ®Google Scholar
• Harris T, Jimenez L, Kawachi N, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol. 2012;180:917–928.
   PubMed Web of Science ®Google Scholar
• Hu C, Lv L, Peng J, et al. MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression. Oncol Lett. 2017;13:4769–4775.
   PubMed Web of Science ®Google Scholar
• Wang Q, Pan Y, Zhao L, et al. Protein Tyrosine Phosphatase 1B(PTP1B) promotes melanoma cells progression through Src activation. Bioengineered. 2021. DOI:10.1080/21655979.2021.1988376
   Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12:414–425.
   PubMed Web of Science ®Google Scholar
• Yuan G, Ding W, Sun B, et al. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance. Bioengineered. 2021;12:4936–4945.
   PubMed Web of Science ®Google Scholar
• Chen D, Shen Z, Cheng X, et al. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression. Bioengineered. 2021;12:1964–1975.
   PubMed Web of Science ®Google Scholar
• Fouad S, Hauton D, D’Angiolella V. E2F1: cause and Consequence of DNA Replication Stress. Front Mol Biosci. 2020;7:599332.
   PubMed Web of Science ®Google Scholar
• Fang Z, Gong C, Liu H, et al. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2. Biochem Biophys Res Commun. 2015;464:407–415.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun X, Bao Y, et al. E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression. Int J Oncol. 2017;51:1639–1650.
   PubMed Web of Science ®Google Scholar
• Lee SR, Roh YG, Kim SK, et al. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer. Clin Cancer Res. 2015;21:5391–5403.
   PubMed Web of Science ®Google Scholar
• Ding M, Lu X, Wang C, et al. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma. Cancer Res. 2018;78:6771–6784.
   PubMedGoogle Scholar
• Cheng H, Jiang W, Song Z, et al. Circular RNA circLPAR3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Upregulating HMGB1 via Sponging miR-375/miR-433. Onco Targets Ther. 2020;13:7759–7771.
   PubMed Web of Science ®Google Scholar
• Zhang K, Wang Q, Zhong B, et al. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression. J Cell Mol Med. 2021;25:4543–4550.
   PubMed Web of Science ®Google Scholar
• Isozaki Y, Hoshino I, Nohata N, et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Int J Oncol. 2012;41:985–994.
   PubMed Web of Science ®Google Scholar
• Chang K, Wei Z, Cao H. miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1beta. Oncol Lett. 2020;20:80.
   PubMed Web of Science ®Google Scholar
• Osako Y, Seki N, Kita Y, et al. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49:2255–2264.
   PubMed Web of Science ®Google Scholar
• Xu H, Jiang J, Zhang J, et al. MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1. Exp Ther Med. 2019;17:1509–1516.
   PubMed Web of Science ®Google Scholar
• Kong KL, Kwong DL, Chan TH, et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut. 2012;61:33–42.
   PubMed Web of Science ®Google Scholar
• Yan JW, Lin JS, He XX. The emerging role of miR-375 in cancer. Int J Cancer. 2014;135:1011–1018.
   PubMed Web of Science ®Google Scholar
• Budanov AV, Lee JH, Karin M. Stressin’ Sestrins take an aging fight. EMBO Mol Med. 2010;2:388–400.
   PubMed Web of Science ®Google Scholar
• Kozak J, Wdowiak P, Maciejewski R, et al. Interactions between microRNA-200 family and Sestrin proteins in endometrial cancer cell lines and their significance to anoikis. Mol Cell Biochem. 2019;459:21–34.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren R, Yang X, et al. Oncogenic role of early growth response-1 in liver cancer through the regulation of the microRNA-675/sestrin 3 and the Wnt/beta-catenin signaling pathway. Bioengineered. 2021;12:5305–5322.
   PubMed Web of Science ®Google Scholar
• Li ZW, Zhang TY, Yue GJ, et al. Small nucleolar RNA host gene 22 (SNHG22) promotes the progression of esophageal squamous cell carcinoma by miR-429/SESN3 axis. Ann Transl Med. 2020;8:1007.
   PubMed Web of Science ®Google Scholar
• Xie Q, Peng S, Tao L, et al. E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors. J Biol Chem. 2014;289:34205–34213.
   PubMed Web of Science ®Google Scholar
• Jing C, Duan Y, Zhou M, et al. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. Theranostics. 2021;11:2655–2669.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang Q, Li M, et al. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA. Biochem Biophys Res Commun. 2014;444:199–204.
   PubMed Web of Science ®Google Scholar